Variations in the exposure to sunitinib with immediate and deferred cytoreductive nephrectomy (CN). A post-hoc analysis of the randomized controlled EORTC SURTIME trial

Variations in the exposure to sunitinib with immediate and deferred cytoreductive nephrectomy (CN). A post-hoc analysis of the randomized controlled EORTC SURTIME trial

Bibliographic Details
Main Authors:	Y. Abu-Ghanem, H. Van Thienen, C. Blank, T. Powles, L. Collette, B. Tombal, J. Haanen, A. Bex
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320334339

Similar Items

Cytoreductive nephrectomy in the current treatment algorithm
by: Teele Kuusk, et al.
Published: (2019-09-01)

Cytoreductive Nephrectomy and Nephrectomy/Complete Metastasectomy for Metastatic Renal Cancer
by: Paul Russo, et al.
Published: (2007-01-01)

Cytoreductive nephrectomy for metastatic renal cell carcinoma
by: Rajendra B Nerli
Published: (2013-01-01)

The current role of cytoreductive nephrectomy for metastatic renal cell carcinoma
by: Eric C Umbreit, et al.
Published: (2021-01-01)

Cytoreductive nephrectomy and its role in the present-day period of targeted therapy
by: Stephen H. Culp
Published: (2015-10-01)

The role of cytoreductive nephrectomy in renal cell carcinoma patients with liver metastasis
by: Boda Guo, et al.
Published: (2020-07-01)

Command languages and the expression of immediate and deferred action
by: Keeffe, D.
Published: (1984)

Predictors of Cytoreductive Nephrectomy for Metastatic Kidney Cancer in SEER and Metropolitan Detroit Databases
by: Ulka Vaishampayan, MD, et al.
Published: (2019-10-01)

Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?
by: Alex Renner, et al.
Published: (2019-03-01)

Predictors for perioperative complications in cytoreductive nephrectomy: Analysis of the registry for metastatic RCC (REMARCC)
by: E. Roussel, et al.
Published: (2020-07-01)

The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma
by: Chen J, et al.
Published: (2020-03-01)

3D laparoscopic nephron sparing surgery and cytoreductive nephrectomy: Technical challenges and strategies
by: B. Petrut, et al.
Published: (2020-01-01)

Role of cytoreductive nephrectomy in the targeted therapy era: A systematic review and meta-analysis
by: Herney A. García-Perdomo, et al.
Published: (2018-01-01)

The impact of histology on survival for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy
by: Alonso Carrasco, et al.
Published: (2014-01-01)

The importance of sign and symptoms assessment in patients with metastatic renal cell carcinoma: implications for cytoreductive nephrectomy
by: A. Larcher, et al.
Published: (2020-10-01)

Spontaneous regression of metastatic renal cell carcinoma after cytoreductive nephrectomy: A case report
by: Kuniyasu Muraoka, et al.
Published: (2020-07-01)

Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
by: Yan Song, et al.
Published: (2016-01-01)

A rapid progression of new metastatic lesion after cytoreductive nephrectomy: A case report
by: Steven Steven, et al.
Published: (2021-11-01)

The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases.
by: Zhijian Zhao, et al.
Published: (2019-01-01)

Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
by: Jacob J. Adashek, et al.
Published: (2021-02-01)

Validation of preoperative variables and stratification of patients to help predict benefit of cytoreductive nephrectomy in the targeted therapy ERA
by: Brandon J. Manley, et al.

The correlations of abilities in immediate and deferred memory for prose passages with other measures of intelligence
by: Homan, Thomas Benjamin
Published: (1917)

The role of cytoreductive nephrectomy in the contemporary management of metastatic kidney cancer: Predictive factors for surgical complications and oncological survival
by: E. Roussel, et al.
Published: (2020-07-01)

Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
by: Khoshnevisan Alireza, et al.
Published: (2012-05-01)

A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection
by: Ubolyam Sasiwimol, et al.
Published: (2008-10-01)

Measuring Prostate Cancer Quality of Life:Psychometric Properties of the EORTC-C30 and EORTC-PR25
by: Yu-Jun Chang, et al.
Published: (2008)

COMPARATIVE ANALYSIS OF THE COURSE OF CHRONIC KIDNEY DISEASE (CKD) IN PATIENTS WITH DIFFERENT STAGES OF RENAL CANCER AFTER RADICAL AND CYTOREDUCTIVE NEPHRECTOMY
by: S. M. Pasichnyk, et al.
Published: (2017-11-01)

Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature
by: Scott J. Dawsey, et al.
Published: (2021-05-01)

Minimally invasive versus open cytoreductive nephrectomy for primary metastatic renal cancer: A multi-institutional experience from the REMARCC registry
by: R. Campi, et al.
Published: (2020-07-01)

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry
by: Alexandr Poprach, et al.
Published: (2020-10-01)

Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
by: Cheng Li, et al.
Published: (2021-08-01)

Cytoreductive Nephrectomy Promoted Abscopal Effect of Camrelizumab Combined With Radiotherapy for Metastatic Renal Cell Carcinoma: A Case Report and Review of the Literature
by: Min Wu, et al.
Published: (2021-06-01)

Validity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer
by: Fernanda Alessandra Silva Michels, et al.
Published: (2013-06-01)

DEFERRED STENTING VERSUS IMMEDIATE STENTING TO PREVENT NO- OR SLOW REFLOW IN ACUTE ST-ELEVATION MYOCARDIAL INFARCTION
Published: (2016-03-01)

Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
by: Bernaschi Massimo, et al.
Published: (2009-10-01)

To Defer or Not Defer? The Challenges of Physiology in Acute Coronary Syndromes
by: Carlos M. Campos, et al.

International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26
by: Monika Sztankay, et al.
Published: (2018-11-01)

Lymph node dissection is associated with decreased survival and all cause mortality among patients undergoing cytoreductive nephrectomy for metastatic renal cell carcinoma
by: S. Weprin, et al.
Published: (2020-07-01)

Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a SEER analysis
by: Wen-Jun Xiao, et al.
Published: (2015-04-01)

In deference to reference
by: Segal, Gabriel Mark Aurel
Published: (2009)

Cannot write session to /tmp/vufind_sessions/sess_av5ctv9bglti8ufq09g7tmkmf7